Skip to main content
logo
CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
0.9800
+0.0502 (5.40%)
At close: Oct 7, 2026, 4:00 PM EDT
0.9069
-0.0731 (-7.46%)
After-hours: Oct 7, 2026, 4:08 PM EDT

CytoMed Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
12153956--
Market Cap Growth
-49.58%-60.73%-30.55%---
Enterprise Value
11143549--
Last Close Price
0.981.333.404.90--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
19.1823.02106.38146.86--
PB Ratio
3.042.895.926.63--
P/TBV Ratio
3.113.096.046.64--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
17.9120.3393.59127.72--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.080.070.050.047.201.26
Net Debt / Equity Ratio
-0.19-0.23-0.50-0.764.500.28
Net Debt / EBITDA Ratio
0.280.421.612.47-1.80-0.52
Net Debt / FCF Ratio
0.240.371.102.38-1.41-0.32
Asset Turnover
0.100.100.050.060.060.02
Inventory Turnover
0.120.090.040.010.020.01
Quick Ratio
1.513.148.3912.830.390.86
Current Ratio
2.645.179.8914.080.601.12
Return on Equity (ROE)
-56.17%-50.28%-24.86%-69.87%-197.08%-133.79%
Return on Assets (ROA)
-32.52%-29.31%-17.44%-27.30%-20.55%-21.98%
Return on Capital Employed (ROCE)
-69.10%-58.20%-33.10%-33.00%-175.10%-55.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-23.17%-20.09%-4.70%-5.54%--
FCF Yield
-28.20%-21.88%-7.68%-4.81%--
Buyback Yield / Dilution
-2.40%-0.93%-8.56%-34.30%-14.14%-17.59%
SEC Filings: 10-K · 10-Q